Company Name | Asston Pharmaceutical Limited |
Open Date | 09-07-2025 |
Close Date | 11-07-2025 |
Exchange | BSE SME |
Lot Size | 1,000 Shares |
Issue Price | ₹115 to ₹123 per share |
Issue Size | 22,41,000 shares |
Application Amount | ₹2,46,000 |
Recommendation | Avoid |
KPIs | Mar-22 | Mar-23 | Mar-24 |
Revenue | 653.80 | 1,558.62 | 2,503.92 |
EBITDA | 151.66 | 254.59 | 615.93 |
Net Profit | 105.67 | 136.04 | 432.51 |
RoCE | 37.88% | 30.42% | 46.28% |
ROE | 53.21% | 21.28% | 40.35% |
P/E | 65.08 | 51.90 | 17.83 |
Opening Date | 09-07-2025 |
Closing Date | 11-07-2025 |
Basis of Allotment | 14-07-2025 |
Initiation of Refunds | 15-07-2025 |
Credit of Shares to Demat | 15-07-2025 |
Listing Date | 16-07-2025 |
Capital expenditure for acquiring machine in manufacturing unit. |
To meet the working capital requirements. |
Repayment of borrowings availed by the company. |
General Corporate Purposes. |
Registered Office | 4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane Navi Mumbai, Maharashtra, 400614 |
Phone | +91 22 49731411 |
info@asstonpharmaceuticals.com | |
Website | http://www.asstonpharmaceuticals.com/ |
Name | Maashitla Securities Private Limited |
Phone | +91-11-45121795-96 |
ipo@maashitla.com | |
Website | https://maashitla.com/allotment-status/public-issues |
NII (HNI) Shares Offered | 3,22,000 (14.37%) |
Retail Shares Offered | 7,46,000 (33.29%) |
QIB Shares Offered | 10,60,000 (47.30%) |
Market Maker Shares Offered | 1,13,000 (5.04%) |
Share Holding Pre Issue (Promoters) | 68.76% |
Share Holding Post Issue (Promoters) | 50.66% |